Value of hypertension market India FY 2020, by drug class

Published by A. Minhas, Jul 12, 2023
Angiotensin had the highest market share in the hypertension drug segment and was worth about 41 billion Indian rupees in financial year 2020. Beta Blockers had the second highest market value among the drug classes in hypertension that same year.

Value of hypertension market across India in financial year 2020, by drug class (in billion Indian rupees)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2020

Region

India

Survey time period

FY 2020

Supplementary notes

India's financial year begins in April and ends in March. For example, FY 2020 started in April 2019 and ended in March 2020.

One Indian rupee is equal to 0.011 euros and 0.014 U.S. dollars as of January 2021.

Values have been rounded for clarity.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Cardiovascular disease in India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Cardiovascular disease in India

Overview

5

Heart disease

5

Hypertension

4

Leading cardiac therapies

4

Leading cardiac brands and molecules

7

Leading market players

7

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Cardiovascular disease in IndiaCardiovascular disease in the U.S.Cardiovascular disease in the UK
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.